BrainLab gains FDA OK for sinus surgery software:
This article was originally published in Clinica
German company BrainLab has gained FDA 510(k) clearance to sell its Kolibri ENT image-guided surgery software for use during ENT (ear, nose and throat) surgery in the US. The system, which is intended specifically for use in sinus surgery, enables surgeons to track pre-existing surgical instruments and to integrate real-time endoscopic video, says the Munich firm. The technology also features a tool tip offset, allowing surgeons to virtually navigate deep into the patient's sinuses, the firm adds.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.